Radiant Biotherapeutics raised $35 million in a Series A financing co-led by the Bill & Melinda Gates Foundation and Amplitude Ventures to advance its lead clinical candidate towards trials.
Amount Raised
$35 Million
Round Type
Series A
TorontoBiotechnologyHealth CareTherapeuticsInvestors
Description
Radiant Biotherapeutics has closed a $35 million Series A financing round to support the development of its proprietary Multabody™ platform. The funding will help the company advance its lead clinical candidate, 4-1BB, towards clinical trials.
Quick answer
Radiant raised $35 Million in a Series A round, dated September 11, 2024. Investors: Toronto Innovation Acceleration Partners, Alexandria Venture Investments, Facit, Abrdn, BDC Capital, Amplitude Ventures and Bill & Melinda Gates Foundation. Radiant is based in Toronto, Ontario, Canada.
- How much did Radiant raise?
- Radiant raised $35 Million in a Series A round on September 11, 2024.
- Who invested in Radiant?
- Toronto Innovation Acceleration Partners, Alexandria Venture Investments, Facit, Abrdn, BDC Capital, Amplitude Ventures and Bill & Melinda Gates Foundation are named as investors in this round.
- What does Radiant do?
- Radiant Biotherapeutics is a revolutionary antibody platform company leading the new frontier of multi-valent, multi-specific therapeutics to deliver transformative therapies for patients.
- Where is Radiant based and how big is it?
- Radiant is based in Toronto, Ontario, Canada.
- Who are the decision-makers at Radiant?
- Fundz holds 1 contact at Radiant. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Radiant that raised within 45 days of this round, from Fundz verified event records.
- Pathos AI raised $62M on October 24, 2024.
- Ensho Therapeutics raised $5M on October 24, 2024.
- AvenCell Therapeutics raised $112M (Series B) on October 22, 2024.
- Passkey Therapeutics raised $20M (Seed) on October 22, 2024.
- TenNor Therapeutics raised $41M (Series E) on October 16, 2024.
- invIOs raised $8.9M (Series A) on October 15, 2024.
Who to call at Radiant, and when
A new round usually means Radiant is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Radiant raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Radiant, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Radiant. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Radiant raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansRadiant raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.